By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – BioSearch Technologies today said that it has licensed patents covering oligonucleotide components to Intelligent Medical Devices (IMDx).

According to the Novato, Calif.-based firm, it has licensed to IMDx access to patents covering its BHQ, CAL Fluor, and Quasar technologies. It also will manufacture cGMP oligonucleotides for Cambridge, Mass.-based IMDx for human in vitro diagnostic use.

Financial and other terms of the alliance were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.